SCHEMBL6919396

SCHEMBL6919396

CNC(=O)C(Cc1ccc([N+](=O)[O-])cc1)N(C(=O)Cc1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
TP53 P04637 1/20 0.48
RAB9A P51151 1/20 0.48
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
OPRK1 P41145 1/20 0.43
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
MMP1 P03956 1/20 0.41
FCER2 P06734 1/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 5/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MMP2 P08253 1/20 0.41
CCR5 P51681 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919388 1.00 MEN1 (0.53) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6808095 0.81 MEN1 (0.52) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6808091 0.81 MEN1 (0.52) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6807740 0.79 MEN1 (0.50) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6807744 0.79 MEN1 (0.50) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6803449 0.76 MEN1 (0.47) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6803444 0.76 MEN1 (0.47) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6828040 0.75 MEN1 (0.70) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL6828028 0.75 MEN1 (0.70) MEN1KMT2ASMN1; SMN2NPC1TP53
SCHEMBL7522803 0.75 MEN1 (0.51) MEN1KMT2ASMN1; SMN2NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE MEN1 4379/4885KMT2A 2262/4885SMN1; SMN2 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.